In addition, treatment with DXM or MTX increased AMPK activity in RA FLSs (Figure S3 in Supplementary Material), in contrast to their effect on GYS1 expression, as shown in Figure S1A in Supplementary Material. This evidence concerns the gene PRKAB1 and rheumatoid arthritis.